|
Kratom: Key Information for Dental Professionals
By J. William "Bill" Claytor, DDS, MAGD
Executive Director, NCCDP
Kratom, derived from the leaves of a Southeast Asian tree, contains active compounds such as mitragynine and 7-hydroxymitragynine (7-OH). Although sometimes referred to informally as “legal morphine,” Kratom currently has no FDA-approved medical use in the United States. Despite this, it is widely perceived by the public as a dietary supplement. Between 2022 and 2024, U.S. use of Kratom products increased significantly—by an estimated five- to eight-fold—with current user estimates ranging from 11 to 16 million people and retail sales exceeding $2.2 billion annually.
In 2016, efforts were made to classify Kratom as a Schedule I substance, indicating high abuse potential and no accepted medical use. The American Kratom Association (AKA) urged federal agencies to postpone scheduling to allow further research. As of today, Kratom is not scheduled federally, but it remains on the DEA’s “Drugs of Concern” list due to ongoing safety questions and reports of misuse.
READ MORE>>>
|